Thank you to all of our attendees, speakers and sponsors for making this event possible.

Keep an eye out for the next event in the D4 series taking place in late 2019.


"A fabulous opportunity to understand what other pharma/biotech companies are doing to accelerate drug development and connect with like-minded colleagues from a well-balanced range of industries” - Bino John, Associate Director, AstraZeneca

“I made more new contacts at the D4 conference than at any conference over the past couple of years." - Peter Henstock, Senior Data Scientist, Software Engineering, Statistics and Visualization, Pfizer.

“A great opportunity to get inside the minds of leading thinkers in leveraging data science and IT to create new drugs.’’ - Steve Hoang, Head of Computational Biology, Hemoshear Therapeutics

‘’A great blend of topics around data-driven drug discovery bringing people from different domains close to each other.’’ Martin Romacker, Principal Scientist, La Roche

’Very well-done conference. You can tell a lot of thought went into its planning. Good size. Good setting. Plenty of time to network. Wide variety of learning opportunities, thought the panel discussions and the Slido technology were especially effective.’’ - Anonymous, Tessella


S1280009 444.jpg

This was the first conference to specifically help pharma and biotech companies build and execute a scalable, sustainable and future-resistant R&D data strategy, including innovative yet accessible new approaches, methods and ways of looking at the data life cycle that drive incredible value within pharma R&D.

D4: Pharma is a highly-select gathering of 80-100 very senior, experienced pharma professionals who are responsible for making important decisions, changes and turning innovation and new ideas into measurable progress. An incredible place for focused learning, intelligence gathering and senior-level networking.


conference-2705706.jpg

Who spoke?

Senior-level speakers attended from Roche, AstraZeneca, Pfizer, Eisai, Regeneron, AbbVie, Biogen, Celgene, Takeda, Novartis, BMS, Alexion, GSK, the FDA and others, including innovative tech companies.

Speaking Organisations:


cellphone-3658089.jpg

Why attend?

If you’re in a senior position in pharma R&D/IT/data, your time is precious. You need to spend it wisely. D4: Pharma focuses on creating value and intelligence/perspectives in an intimate, curated environment that you simply cannot access elsewhere. This is not your standard conference.

The agenda has been carefully crafted from research conducted at 8 boardroom-style meetings in London and Boston across 2018, each of which was used to identify the challenges, priorities and best solutions that are reflected on the agenda. Further interviews were conducted to fine-tune topics and decide on the best format to address each issue.

The result is a series of senior-level presentations and case-studies (from pharma and the FDA) packed into a two-day conference, and augmented with over 10+ hours of networking time, round-table discussions, panels and group sessions. No “death by PowerPoint” here. It’s packed full of engaging sessions where attendees are encouraged to be part of the discussion.

Attendees will leave armed with unrivalled intelligence, tools and solutions to take back to their company. Plus dozens of informal connections to help you lead the change process, make crucial decisions and execute on the near-term progress that is so desperately required.


composition-3309860.jpg

industry-led reports

The agenda for this meeting was carefully crafted from research conducted at 8 invite-only industry meetings involving 100+ senior-level business and scientific leaders from 60+ organizations.

The reports from those meetings are packed full of first-hand intelligence on the challenges, priorities and solutions for pharma/biotech and the wider precision medicine community.